PHOENIX -- Botulinum toxin injections offered relief from sialorrhea, or excessive saliva production, in patients with amyotrophic lateral sclerosis (ALS), according to a small study. The ...

In the clinical evaluations to date, the dose of botulinum toxin type A used to treat gastroparesis ranged from 80 to 200 units. The pyloric sphincter was divided into equal anatomical quadrants, and ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Evidence-based recommendations on botulinum toxin type A injections into the urethral sphincter for idiopathic chronic non-obstructive urinary retention. This involves injecting botulinum toxin type A ...

LONDON--(BUSINESS WIRE)--Technavio has announced the top five leading vendors in their recent global botulinum toxin market report. This research report also lists 23 other prominent vendors that are ...

Two research groups have designed chimeric fusion proteins that constitute a new “trojan horse” approach to neutralize lethal botulinum toxins. Botulinum neurotoxins (BoNTs)—a family of bacterial ...

While rare, botulism can cause paralysis and is potentially fatal. It is caused by nerve-damaging toxins produced by Clostridium botulinum -- the most potent toxins known. These toxins are often found ...

Early preclinical work led by researchers from Harvard Medical School has found certain elements in a toxin produced by the anthrax bacterium can silence activity in pain-signaling brain neurons. The ...

Currently there's no treatment for botulism once the toxin gets into neurons. This novel treatment neutralized the toxin with a second, modified botulinum toxin that delivered a mini antibody into the ...